José Castellote

4.6k total citations
88 papers, 2.2k citations indexed

About

José Castellote is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, José Castellote has authored 88 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Hepatology, 30 papers in Surgery and 30 papers in Epidemiology. Recurrent topics in José Castellote's work include Liver Disease and Transplantation (38 papers), Liver Disease Diagnosis and Treatment (22 papers) and Organ Transplantation Techniques and Outcomes (14 papers). José Castellote is often cited by papers focused on Liver Disease and Transplantation (38 papers), Liver Disease Diagnosis and Treatment (22 papers) and Organ Transplantation Techniques and Outcomes (14 papers). José Castellote collaborates with scholars based in Spain, United Kingdom and United States. José Castellote's co-authors include Xavier Xiol, Carme Baliellas, Jordi Guardiola, Eva Sesé, Joan B. Gornals, Laura Lladó, Antoni Rafecas, Joan Fabregat, Emilio Ramos and Jaume Torras and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and The American Journal of Medicine.

In The Last Decade

José Castellote

84 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
José Castellote Spain 27 1.3k 1.1k 882 457 360 88 2.2k
Xavier Xiol Spain 27 1.6k 1.3× 1.2k 1.1× 1.1k 1.2× 369 0.8× 356 1.0× 86 2.5k
David D. Douglas United States 28 1.7k 1.3× 1.3k 1.3× 1.1k 1.2× 466 1.0× 190 0.5× 75 2.8k
Philippe Ichaı̈ France 32 2.5k 1.9× 1.6k 1.6× 1.8k 2.0× 255 0.6× 251 0.7× 96 3.3k
Marc Deschênes Canada 29 1.7k 1.3× 1.7k 1.6× 845 1.0× 191 0.4× 178 0.5× 88 2.6k
AK Burroughs United Kingdom 22 1.6k 1.3× 1.5k 1.4× 819 0.9× 204 0.4× 101 0.3× 80 2.3k
James R. Burton United States 20 1.4k 1.1× 950 0.9× 913 1.0× 238 0.5× 117 0.3× 48 1.9k
G. Clemente Spain 32 2.0k 1.6× 1.7k 1.6× 951 1.1× 129 0.3× 136 0.4× 90 2.6k
Evangelos Akriviadis Greece 28 2.0k 1.6× 1.9k 1.8× 894 1.0× 160 0.4× 261 0.7× 80 2.8k
Valentín Cuervas‐Mons Spain 29 1.5k 1.1× 1.2k 1.2× 1.3k 1.5× 126 0.3× 385 1.1× 129 2.8k
Mitchell L. Shiffman United States 24 2.7k 2.1× 1.8k 1.7× 1.8k 2.1× 428 0.9× 231 0.6× 43 3.6k

Countries citing papers authored by José Castellote

Since Specialization
Citations

This map shows the geographic impact of José Castellote's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José Castellote with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José Castellote more than expected).

Fields of papers citing papers by José Castellote

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José Castellote. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José Castellote. The network helps show where José Castellote may publish in the future.

Co-authorship network of co-authors of José Castellote

This figure shows the co-authorship network connecting the top 25 collaborators of José Castellote. A scholar is included among the top collaborators of José Castellote based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José Castellote. José Castellote is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Villanueva, B., Pau Cerdà, Esther Alba, et al.. (2024). Minimal encephalopathy in hereditary hemorrhagic telangiectasia patients with portosystemic vascular malformations. Orphanet Journal of Rare Diseases. 19(1). 484–484.
2.
Rigo‐Bonnin, Raül, et al.. (2023). Determination of ertapenem in plasma and ascitic fluid by UHPLC-MS/MS in cirrhotic patients with spontaneous bacterial peritonitis. SHILAP Revista de lepidopterología. 5(2). 173–180. 1 indexed citations
3.
Riera‐Mestre, Antoni, Pau Cerdà, Adriana Iriarte, et al.. (2022). Perioperative Complications and Long-Term Follow-Up of Liver Transplantation in Hemorrhagic Hereditary Telangiectasia: Report of Three Cases and Systematic Review. Journal of Clinical Medicine. 11(19). 5624–5624. 2 indexed citations
4.
Mora‐Luján, José María, Adriana Iriarte, Esther Alba, et al.. (2020). Gender differences in hereditary hemorrhagic telangiectasia severity. Orphanet Journal of Rare Diseases. 15(1). 63–63. 19 indexed citations
5.
Mora‐Luján, José María, Adriana Iriarte, Esther Alba, et al.. (2019). Gastrointestinal Bleeding in Patients with Hereditary Hemorrhagic Telangiectasia: Risk Factors and Endoscopic Findings. Journal of Clinical Medicine. 9(1). 82–82. 23 indexed citations
6.
Escorsell, Àngels, José Castellote, Jordi Sánchez‐Delgado, et al.. (2018). Manejo de la insuficiencia hepática aguda grave. Documento de posicionamiento de la Societat Catalana de Digestologia. Gastroenterología y Hepatología. 42(1). 51–64. 4 indexed citations
7.
Gómez‐Bravo, Miguel Ángel, María Apellániz-Ruiz, Magdalena Salcedo, et al.. (2017). Influence of donor liver CYP3A4*20 loss-of-function genotype on tacrolimus pharmacokinetics in transplanted patients. Pharmacogenetics and Genomics. 28(2). 41–48. 14 indexed citations
8.
Ardèvol, Alba, Gemma Ibáñez‐Sanz, Carles Aracil, et al.. (2017). Survival of patients with cirrhosis and acute peptic ulcer bleeding compared with variceal bleeding using current first‐line therapies. Hepatology. 67(4). 1458–1471. 44 indexed citations
9.
Alía, Pedro, et al.. (2015). Liver Transplant Patient Carriers of Polymorphism Cyp3a5*1 Donors May Need More Doses of Tacrolimus From the First Month After Transplantation. Transplantation Proceedings. 47(8). 2388–2392. 9 indexed citations
10.
Gómez‐Bravo, Miguel Ángel, Magdalena Salcedo, Constantino Fondevila, et al.. (2013). Impact of donor and recipient CYP3A5 and ABCB1 genetic polymorphisms on tacrolimus dosage requirements and rejection in Caucasian Spanish liver transplant patients. The Journal of Clinical Pharmacology. 53(11). 1146–1154. 26 indexed citations
11.
Lladó, Laura, Carme Baliellas, Carlos Casasnovas, et al.. (2010). Risk of transmission of systemic transthyretin amyloidosis after domino liver transplantation. Liver Transplantation. 16(12). 1386–1392. 81 indexed citations
12.
Lladó, Laura, José Castellote, Juan Fabregat, et al.. (2008). Antral mass due to cytomegalovirus infection requiring gastrectomy in a liver transplant recipient. Transplant Infectious Disease. 10(5). 354–357. 4 indexed citations
13.
Castellote, José, Javier Ariza, Rossella Rota, Anna Girbau, & Xavier Xiol. (2008). Serious drug-induced liver disease secondary to ezetimibe. World Journal of Gastroenterology. 14(32). 5098–5098. 18 indexed citations
14.
Sabaté, Mònica, Luisa Ibáñez, E. Pérez, et al.. (2007). Risk of acute liver injury associated with the use of drugs: a multicentre population survey. Alimentary Pharmacology & Therapeutics. 25(12). 1401–1409. 48 indexed citations
15.
Xiol, Xavier, José Castellote, Joan B. Gornals, et al.. (2005). Liver transplantation in patients with hepatic hydrothorax. Transplant International. 18(6). 672–675. 63 indexed citations
16.
Lladó, Laura, José Castellote, & Juan Figueras. (2005). Is retransplantation an option for recurrent hepatitis C cirrhosis after liver transplantation?. Journal of Hepatology. 42(4). 468–472. 12 indexed citations
17.
Figueras, Juan, et al.. (2004). Haemophagocytic syndrome after liver transplantation in adults. Transplant International. 17(4). 221–223. 7 indexed citations
18.
Castellote, José, Carmen López, Joan B. Gornals, et al.. (2003). Rapid Diagnosis of Spontaneous Bacterial Peritonitis by Use of Reagent Strips. Hepatology. 37(4). 893–896. 98 indexed citations
19.
Castellote, José, et al.. (1997). Crohn's Disease and the Myelodysplastic Syndrome. Journal of Clinical Gastroenterology. 24(4). 286–287. 10 indexed citations
20.
Guardiola, Jordi, Xavier Xiol, Josep M. Escribà, et al.. (1995). Prognosis assessment of cirrhotic patients with refractory ascites treated with a peritoneovenous shunt.. PubMed. 90(12). 2097–102. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xavier Xiol Breakdown of academic impact, for papers by David D. Douglas Breakdown of academic impact, for papers by Philippe Ichaı̈ Breakdown of academic impact, for papers by Marc Deschênes Breakdown of academic impact, for papers by AK Burroughs Breakdown of academic impact, for papers by James R. Burton Breakdown of academic impact, for papers by G. Clemente Breakdown of academic impact, for papers by Evangelos Akriviadis Breakdown of academic impact, for papers by Valentín Cuervas‐Mons Breakdown of academic impact, for papers by Mitchell L. Shiffman
Rankless by CCL
2026